TY - JOUR
T1 - Characteristics and Outcomes of Sepsis Presenting in Inpatient Pediatric Settings
AU - Improving Pediatric Sepsis Outcomes (IPSO) Collaborative Investigators
AU - Schafer, Melissa
AU - De Souza, Heidi Gruhler
AU - Paul, Raina
AU - Riggs, Ruth
AU - Richardson, Troy
AU - Conlon, Patricia
AU - Duffy, Susan
AU - Foster, Lauren Z.
AU - Gunderson, Julie
AU - Hall, David
AU - Hatcher, Laura
AU - Hess, Lauren M.
AU - Kirkpatrick, Lauren
AU - Kunar, Jillian
AU - Lockwood, Justin
AU - Lowerre, Tracy
AU - McFadden, Vanessa
AU - Raghavan, Anita
AU - Rizzi, Jennifer
AU - Stephen, Rebecca
AU - Stokes, Stacey
AU - Workman, Jennifer K.
AU - Kandil, Sarah B.
AU - Alqahtani, Mashael F.
AU - Auletta, Jeffery J.
AU - Barnett, Audrey H.
AU - Brilli, Richard J.
AU - Campbell, Deborah R.
AU - Chang, Pearl W.
AU - Chatterjee, Ashmita
AU - DeMartini, Theodore K.M.
AU - Depinet, Holly
AU - Dykstra-Nykanen, Jill B.
AU - Erdem, Guliz
AU - Fitzgerald, Julie C.
AU - Frizzola, Meg
AU - Graham, Rachel E.
AU - Grant, Amy R.
AU - Hakim, Hana
AU - Harris, Baila S.
AU - Hueschen, Leslie A.
AU - Huskins, W. Charles
AU - Jacob-Freese, Jennifer
AU - Khoury, Raed M.
AU - Larsen, Gitte Y.
AU - Laurich, Vincent M.
AU - Little, Hadassah L.
AU - Loberger, Jeremy M.
AU - Macias, Charles G.
AU - Mack, Elizabeth H.
N1 - Publisher Copyright:
Copyright © 2022 by the American Academy of Pediatrics.
PY - 2022/12
Y1 - 2022/12
N2 - OBJECTIVE: The pediatric sepsis literature lacks studies examining the inpatient setting, yet sepsis remains a leading cause of death in children’s hospitals. More information is needed about sepsis arising in patients already hospitalized to improve morbidity and mortality outcomes. This study describes the clinical characteristics, process measures, and outcomes of inpatient sepsis cases compared with emergency department (ED) sepsis cases within the Improving Pediatric Sepsis Outcomes data registry from 46 hospitals that care for children. METHODS: This retrospective cohort study included Improving Pediatric Sepsis Outcomes sepsis cases from January 2017 to December 2019 with onset in inpatient or ED. We used descriptive statistics to compare inpatient and ED sepsis metrics and describe inpatient sepsis outcomes. RESULTS: The cohort included 26 855 cases; 8.4% were inpatient and 91.6% were ED. Inpatient cases had higher sepsis-attributable mortality (2.0% vs 1.4%, P = .025), longer length of stay after sepsis recognition (9 vs 5 days, P <.001), more intensive care admissions (57.6% vs 54.1%, P = .002), and greater average vasopressor use (18.0% vs 13.6%, P <.001) compared with ED. In the inpatient cohort, >40% of cases had a time from arrival to recognition within 12 hours. In 21% of cases, this time was >96 hours. Improved adherence to sepsis treatment bundles over time was associated with improved 30-day sepsis-attributable mortality for inpatients with sepsis. CONCLUSIONS: Inpatient sepsis cases had longer lengths of stay, more need for intensive care, and higher vasopressor use. Sepsis-attributable mortality was significantly higher in inpatient cases compared with ED cases and improved with improved sepsis bundle adherence.
AB - OBJECTIVE: The pediatric sepsis literature lacks studies examining the inpatient setting, yet sepsis remains a leading cause of death in children’s hospitals. More information is needed about sepsis arising in patients already hospitalized to improve morbidity and mortality outcomes. This study describes the clinical characteristics, process measures, and outcomes of inpatient sepsis cases compared with emergency department (ED) sepsis cases within the Improving Pediatric Sepsis Outcomes data registry from 46 hospitals that care for children. METHODS: This retrospective cohort study included Improving Pediatric Sepsis Outcomes sepsis cases from January 2017 to December 2019 with onset in inpatient or ED. We used descriptive statistics to compare inpatient and ED sepsis metrics and describe inpatient sepsis outcomes. RESULTS: The cohort included 26 855 cases; 8.4% were inpatient and 91.6% were ED. Inpatient cases had higher sepsis-attributable mortality (2.0% vs 1.4%, P = .025), longer length of stay after sepsis recognition (9 vs 5 days, P <.001), more intensive care admissions (57.6% vs 54.1%, P = .002), and greater average vasopressor use (18.0% vs 13.6%, P <.001) compared with ED. In the inpatient cohort, >40% of cases had a time from arrival to recognition within 12 hours. In 21% of cases, this time was >96 hours. Improved adherence to sepsis treatment bundles over time was associated with improved 30-day sepsis-attributable mortality for inpatients with sepsis. CONCLUSIONS: Inpatient sepsis cases had longer lengths of stay, more need for intensive care, and higher vasopressor use. Sepsis-attributable mortality was significantly higher in inpatient cases compared with ED cases and improved with improved sepsis bundle adherence.
UR - http://www.scopus.com/inward/record.url?scp=85150295686&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85150295686&partnerID=8YFLogxK
U2 - 10.1542/hpeds.2022-006592
DO - 10.1542/hpeds.2022-006592
M3 - Article
C2 - 36345706
AN - SCOPUS:85150295686
SN - 2154-1663
VL - 12
SP - 1048
EP - 1057
JO - Hospital Pediatrics
JF - Hospital Pediatrics
IS - 12
ER -